Logo     Print Page  Close Window


SEC Filings


10-Q
FIBROCELL SCIENCE, INC. filed this Form 10-Q on 08/09/2018
Entire Document
 



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
FIBROCELL SCIENCE, INC.
 
 
By:
/s/ John M. Maslowski
 
John M. Maslowski
 
President and Chief Executive Officer
 
(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
 
 
Date:
August 9, 2018


43